|
|
||
| API | DOSSAGE/ FORM | DOSSIER |
| Amlodipine | 2.5-5 mg, Orally disintegrated tablets | Dossier under development |
| Buprenorphine | 0,4-2-8 mg, sublingual tablets | EEC Registrations and/or Dossier ready |
| Diltiazem | 60-90-120-180-240-300 mg, SR pellets in capsules | EEC Registrations and/or Dossier ready |
| Donepezil | 5-10 mg, Orally disintegrated tablets | Dossier under development |
| Doxycycline | 100-200 mg, Oesophago-protected pellets in tablets | EEC Registrations and/or Dossier ready |
| Esomeprazole EC | 20-40 mg, Modified release capsule and tablet | Dossier under development |
| Fenofibrate | 67-200 mg, Micronised pellets in capsules | EEC Registrations and/or Dossier ready |
| Fenofibrate | 160 mg, tablet | EEC Registrations and/or Dossier ready |
| Fenofibrate | 130 mg, Micronised pellets in capsules | EEC Registrations and/or Dossier ready |
| Fluoxetine | 20 mg, Orally disintegrated tablets | Dossier under development |
| Isosorbide Mononitrate | 20-40-50-60 mg, SR pellets in capsules | EEC Registrations and/or Dossier ready |
| Ketoprofen | 100-200 mg, SR pellets in capsules | EEC Registrations and/or Dossier ready |
| Ketoprofen- Omeprazole | 100 mg/ 20 mg,100 mg/ 10 mg,150 mg/ 20 mg,200 mg/ 20 mg | EEC Registrations and/or Dossier ready |
| Loratadine | 10 mg, Orally disintegrated tablets | Dossier under development |
| Meloxicam | 7.5-15 mg, Orally disintegrated tablets | Dossier under development |
| Minocycline | 50-100 mg, IR pellets in capsules | EEC Registrations and/or Dossier ready |
| Mirtazapine | 15-30-45 mg, Orodispersible tablets | EEC Registrations and/or Dossier ready |
| Morphine Sulphate | 10-30-60-100-200 mg, BID, SR pellets in capsules | EEC Registrations and/or Dossier ready |
| Morphine Sulphate | 20-40-60-120-200 mg, OAD, SR pellets in capsules | EEC Registrations and/or Dossier ready |
| Morphine Sulphate | 5-10-20-30 mg, IR pellets in capsules | EEC Registrations and/or Dossier ready |
| Nicardipine SR | 50 MG, Modified release capsule and tablet | Dossier under development |
| Omeprazole | 10-20-40 mg, Enteric coated pellets in capsules | EEC Registrations and/or Dossier ready |
| Ondansetron | 4-8 mg, Orodispersible tablets | EEC Registrations and/or Dossier ready |
| Oxycodone | 5-10-20 mg, Orally disintegrated tablets | Dossier under development |
| Oxycodone SR | 10-20-40-80 mg, BID Modified release capsule and tablet | Dossier under development |
| Oxycodone SR | 20-40-80-120 mg, OAD, capsule | Dossier under development |
| Oxycodone SR | 20-40-80-120 mg, OAD, tablet | Dossier under development |
| Paracetamol | 125-250-500 mg, Orodispersible tablets | EEC Registrations and/or Dossier ready |
| Risperidone | 0.5-1-2-3-4 mg, Orally disintegrated tablets | Dossier under development |
| Secnidazole | 250-500 mg-2 g, taste masked pellets in sachets | EEC Registrations and/or Dossier ready |
| Tramadol | 50-100-150-200 mg, SR pellets in capsules | EEC Registrations and/or Dossier ready |
| Tramadol | 50 mg, Orodispersible tablets | EEC Registrations and/or Dossier ready |
| Venlafaxine SR | 37.5-75-150 mg, Modified release capsule | Dossier under development |